EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Establishment of Dementia Platform Korea and the Trial Ready Registry to advance Alzheimer's disease research in Korea

Haeng Jun Kim, Ki Woong Kim, Sang Won Seo, Jong-Min Lee, Sun Jae Jung, Ji Won Han, Hyemin Jang, Jin Hyeong Jhoo, Jeong Lan Kim, Hee Won Yang, Eosu Kim, Il Han Choo und 5 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Haeng Jun Kim und 16 weiteren Autor:innen. Beteiligte Einrichtung: Korea Dementia Research Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Registries, Biomedical Research. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an abundance of high‐quality clinical data and resources for Alzheimer's disease (AD) in Korea. To investigate therapeutic targets and biomarkers, and to progress the AD research field in Korea by standardizing the dementia dataset in Korea, the Trial Ready Registry (TRR) and Dementia Platform Korea (DPK) were developed. We designed the minimum common dataset (MCD) to collect data on patients with AD and human‐derived materials, which consist of clinical data and positron emission tomography (PET) imaging, including both florbetaben (FBB)‐PET and flutematamol (FMM)‐PET. The TRR‐DPK system is planning to enroll 3000 participants prospectively by 2028. As of December 2024, 1765 people have been recruited since 2020.We collected human‐derived materials linked with imaging and clinical data to enable their distribution to qualified researchers for research purposes. We expect that the TRR‐DPK system will improve AD research by providing researchers access to human‐derived materials and quality‐controlled data. Highlights The Trial Ready Registry (TRR) was developed to standardize the dataset for Korean dementia research. At the end of the project, 3000 minimum common dataset (MCD) and blood specimens of participants would be stored and distributed. Currently, 1765 blood specimens and MCD data are available to for researchers in Korea. Blood specimens and MCD data, such as brain image data, and clinical data are available for Korean researchers at www.dpk.re.kr.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseRegistriesBiomedical ResearchHumansRepublic of KoreaPositron-Emission TomographyMale

Stichwörter der Autor:innen

Alzheimer's diseasehighly accessible standardized dataminimum common datasettrial‐ready registry

Autor:innen und Institutionen

  • Korea Dementia Research Center, Seoul, Republic of Korea.
  • Department of Brain and Cognitive Science, Seoul National University College of Natural Science, Seoul, Republic of Korea.
  • Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.
  • Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Institute of Human Behavioral Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea.
  • Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.

Förderung

  • Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea

Zitieren

APA

Kim, H. J., Kim, K. W., Seo, S. W., Lee, J. M., Jung, S. J., Han, J. W., Jang, H., Jhoo, J. H., Kim, J. L., Yang, H. W., Kim, E., Choo, I. H., Kim, S., Kim, K. H., Lee, J., Mook-Jung, I., & TRR research group (2026). Establishment of Dementia Platform Korea and the Trial Ready Registry to advance Alzheimer's disease research in Korea. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71040

Vancouver

Kim HJ, Kim KW, Seo SW, Lee JM, Jung SJ, Han JW, et al. Establishment of Dementia Platform Korea and the Trial Ready Registry to advance Alzheimer's disease research in Korea. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71040

BibTeX
@article{Kim2026,
  author = {Kim, Haeng Jun and Kim, Ki Woong and Seo, Sang Won and Lee, Jong-Min and Jung, Sun Jae and Han, Ji Won and Jang, Hyemin and Jhoo, Jin Hyeong and Kim, Jeong Lan and Yang, Hee Won and Kim, Eosu and Choo, Il Han and Kim, Seonggyu and Kim, Kyeong Ho and Lee, Jihyun and Mook-Jung, Inhee and TRR research group, TRR research group},
  title = {Establishment of Dementia Platform Korea and the Trial Ready Registry to advance Alzheimer's disease research in Korea},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71040}
}
Kostenlos starten →